|
Press Digest
Press digest - year 2026
| "Sopharma Buildings" REIT has concluded with "DSK Bank" AD a Standard Investment Loan Agreement in the amount of 28,121,000 euros, the special purpose vehicle announced. The document was signed on January 21. The loan will be used to finance/refinance, excluding VAT, expenses related to the acquisition and commissioning of "Residential buildings with shops, a kindergarten, underground garages and above-ground parking spaces - Stage I", under construction on its own land in Sofia, 3 Kliment Ohridski Blvd. The loan bears annual interest on regular principal, formed by a variable reference interest rate, representing a weighted average deposit index (WADI) plus an agreed premium of 3.5 percent. The drawdown period is until December 31, 2027, with a grace period on the principal until March 31, 2028 and a repayment deadline of December 31, 2028. On January 21, Sopharma Buildings concluded an annex to the Standard Investment Loan Agreement signed on December 4, 2024 between Sopharma Buildings and DSK Bank AD. This annex changes the amount of the annual interest on the regular principal of the loan, formed by a variable reference interest rate, representing a weighted average deposit index plus an agreed premium, as the agreed premium is reduced from 4.9% to 3.5%. Sopharma AD is the largest shareholder with 32.71% of the capital. Source: Banker (23.01.2026) |
| Sopharma Buildings REIT (SFB)
Notification of a signed annex on 21 January 2026 to the standard investment loan agreement with CB DSK Bank dated 04 December 2024 Source: BSE (23.01.2026) |
| Sopharma Buildings REIT (SFB)
Notification of a signed on 21 January 2026 standard investment loan agreement for EUR 28,121,000 with CB DSK Bank Source: BSE (23.01.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented quarterly report for the Fourth Quarter of 2025. Source: BSE (30.01.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented quarterly report for the Fourth Quarter of 2025. Source: BSE (30.01.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT publishes Annual Individual Financial Statement for the year ended 31-12-2025. Source: BSE (10.03.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT informs that on 27.04.2026 it finalized a transaction for the sale of its own real estate located in the city of Burgas. Source: BSE (28.04.2026) |
| At its meeting on 28.04.2026, the FSC decided:
1. To issue a license to "Bilar" EOOD to operate as a crypto-asset service provider. The company has the right to provide crypto-asset services as follows:
– provision of custody and administration of crypto-assets on behalf of clients;
– execution of orders related to crypto-assets on behalf of clients;
– provision of portfolio management related to crypto-assets.
2. Approves Milen Keremedchiev as a new member of the board of directors of "Fond Imoti" REIT.
3. Approves the submitted changes to the articles of association of "Sopharma Buildings" REIT.
4. Deletes the registration of the Bulgarian Stock Exchange AD as a benchmark administrator and removes the company from the register of benchmark administrators licensed or registered by the Commission under Regulation (EU) 2016/1011.
7. Terminates the proceedings in connection with the issuance of approval to a new member of the board of directors of the management company Thracian Invest EAD.
8. Exempts for 2026 Aurubis Bulgaria AD from the obligation to obtain a license as an investment intermediary in connection with the company's trading in commodity derivatives or emission allowances or their derivatives (within the meaning of Art. 5 of the MFIA).
9. Sends a letter to FF Digital EOOD requesting additional information and documents in connection with the issuance of a permit to operate as a crypto-asset service provider. Source: Company information (29.04.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented quarterly report for Q1 2026. Source: BSE (04.05.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT convenes a regular General Meeting of Shareholders on 18.06.2026 at 11:00 a.m. in Sofia, 5 Lachezar Stanchev Str., Sopharma Business Towers Complex, Building A, floor 20, with the following agenda:
- Report of the management bodies on the company's activities in 2025;
- Adoption of the company's annual financial statements for 2025;
- Report of the registered auditor for 2025;
- Report of the audit committee for 2025;
- Report of the Investor Relations Director for 2025;
- Adoption of a report on the implementation of the Remuneration Policy for the members of the management bodies;
- Discharge of the members of the management bodies from liability for their activities in 2025;
- Election of a registered auditor for 2026;
- Changes in the audit committee and determination of the remuneration of its members;
- Changes in the company's articles of association;
- Decision on the distribution of financial results. Draft decision: No dividend is distributed, since the company ended the reporting year 2025 with a negative financial result in the amount of BGN 233,772.40, and after its transformation in accordance with Art. 29, para. 3 of the Act on the Formation of Companies and the Transfer of Assets and Liabilities – a loss in the amount of BGN 756,956.03. The formed loss for 2025, in the amount of EUR 119,525.93, shall be covered by the accumulated reserves from the Reserve Fund;
- Determination of the amount of remuneration of the members of the management bodies.
- Adoption of changes in the policy for the remuneration of the members of the management bodies.
- In the absence of a quorum, the meeting will be held on 03.07.2026 at 11.00 a.m. at the same place and with the same agenda.
The right to vote at the GMS is exercised by the persons registered as such with the right to vote in the central securities register 14 days before the date of the GMS, or as of 04.06.2026.
The last date for concluding transactions with shares of this company on the Exchange, as a result of which the acquirer will be able to exercise the right to vote at the GMS, is 02.06.2026 (Ex-Date: 03.06.2026) Source: BSE (19.05.2026) |
| Sopharma Buildings REIT (SFB)
Announcement of decisions adopted at the regular AGM held on 18.06.2026 Source: BSE (19.06.2026) |
| Sopharma Buildings REIT (SFB)
At the regular General Meeting of Shareholders of Sopharma Buildings REIT held on 18.06.2026, the following decisions were made:
- Adopts the report of the management bodies on the company's activities in 2025;
- Adopts the annual financial statement of the company for 2025;
- Adopts the report of the registered auditor on the audit of the annual
- Adopts the report of the audit committee for 2025;
- Adopts the report of the director of investor relations for 2025;
- Adopts the report on the implementation of the policy on the remuneration of the members of the management bodies;
- Discharges the members of the management bodies from liability for their activities in 2025;
- Determines the amount of the remuneration of the members of the management bodies;
- Elects a registered auditor for 2026;
- Adopts changes in the audit committee and determination of the remuneration of its members
- Adopts changes in the policy for the remuneration of the members of the management bodies.
- Adopts changes in the company's articles of association;
- Decision on the distribution of financial results. Does not distribute a dividend, since the company ended the reporting year 2025 with a negative financial result in the amount of BGN 233,772.40, and after its transformation in accordance with Art. 29, para. 3 of the Act on the Formation of Private Companies – a loss in the amount of BGN 756,956.03. The formed loss for 2025, in the amount of EUR 119,525.93, shall be covered by the accumulated reserves from the Reserve Fund; Source: BSE (19.06.2026) |
| Ñîôàðìà áèëäèíãñ ÀÄÑÈÖ (SFB)
Ñîôàðìà áèëäèíãñ ÀÄÑÈÖ ïðåäñòàâè òðèìåñå÷åí îò÷åò çà Âòîðî òðèìåñå÷èå íà 2026 ã. Source: BSE (31.07.2026) |
| At a meeting of the Bulgarian Stock Exchange Index Commission, under Minutes No. 8 of 08.09.2026, the following decisions were made:
III. In connection with item 8 of Appendix No. 3 (Methodology for calculating BG REIT) to the Rules for calculating indices of the Bulgarian Stock Exchange, the Index Commission determines the following free-float coefficients for the issues included in the BG REIT base, which will enter into force as of 21.09.2026:
Stock code Issuer Free-float coefficient
ATER Advance Terrafund REIT 0.6081
BSP Balkan & Sea Properties REIT 0.4110
CCBR Grand Vision Properties REIT 0.5092
RPF Roy Property Fund REIT 0.4600
SFB Sopharma Buildings REIT 0.2701
SBPF Super Borovets Property Fund REIT 0.5481
BREF Bulgaria Real Estate Fund REIT 0.7366
The free float data for BG REIT issues is the median value for the period from 02.06.2026 to 01.09.2026
IV. In connection with item 22 of the Rules for calculating the index of companies on the beam market (beamX), the Index Commission determines the following free-float coefficients for the issues included in the beamX database, which will enter into force as of 21.09.2026:
Stock code Issuer Free-float coefficient
ITF ITF Group AD 0.1148
BDT Biodit AD 0.1706
BLRN Boleron AD 0.2145
DRON Dronamix Capital AD 0.9492
HRC HR Capital AD 0.1820
IMP Impulse Growth AD 0.8707
IPSP IpoTech Sofcom AD 0.5957
MFG MFG Invest AD 0.1300
PAY Peysera Bulgaria AD 0.2170
WIN Webbit Investment Network AD 0.8925
The free-float data of the issues from beamX is a median value for the period from 02.06.2026 to 01.09.2026.
V. In connection with item 15 of the Rules for calculating the index of companies with good corporate governance CGIX, the Index Commission determines the following free-float coefficients of the issues included in the CGIX base, which will enter into force as of 21.09.2026.
Stock code Issuer Free-float coefficient
AGH Agria Group Holding AD 0.1860
BSE Bulgarian Stock Exchange AD 0.4995
DUH Doverie United Holding AD 0.6376
SIRM Sirma Group AD 0.5988
SFA Sopharma AD 0.3390
CCB TB Central Cooperative Bank AD 0.1666
SLYG Shelly Group ED 0.2866
The free-float data for CGIX issues is a median value for the period from 02.06.2026 to 01.09.2026
VI. The Index Commission will determine the weighting factors of the issues included in the BSE index bases (including the beam market companies index) and the CGIX index based on the respective "closing" prices as of 18.09.2026
VII. The next meeting of the Index Commission, at which free-float coefficients of the issues included in the BSE indices (including the index of companies on the beam market) and the CGIX index will be determined, will be held on 02.12.2026, and these coefficients will enter into force as of 21.12.2026. Source: BSE (09.09.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT has submitted its quarterly report for the third quarter of 2026. Source: BSE (30.10.2026) |
| Sopharma Buildings REIT (SFB)
On November 16, 2026, Sopharma Buildings REIT finalized a transaction for the sale of its own real estate, in accordance with a decision by the Board of Directors dated October 23, 2026. Source: BSE (17.11.2026) | |